Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Medical progress: Acromegaly
For further prognostic evaluation and clinical decision-making, breast cancer can be classified into three subgroups based on immunohistochemical staining results for ER, PR, and HER2: HR-positive/HER2negative (HR+/HER2, ~70%), HER2positive (HER2+, ~1520%), and triple-negative breast cancer [TNBC, HR-negative (HR-), HER2, ~15%]
doi:10.1016/j.bmcl.2018.07.009
A significant contribution of this study is the incorporation of hypothesis-based incremental metabolic zonation pattern (20%, 50%, and 80%) and the analysis of its effect on cellular injury outcomes, i.e., cell necrosis
US$ 22.56
US$ 20.60
US$ 29.37
US$ 24.39
US$ 22.56
